New Zealand - English - Medsafe (Medicines Safety Authority)

schering-plough a division of schering-plough animal health limited - dexchlorpheniramine maleate 6mg (3mg in core and 3mg in coat);  ; dexchlorpheniramine maleate 6mg (3mg in core and 3mg in coat) - modified release tablet - 6 mg - active: dexchlorpheniramine maleate 6mg (3mg in core and 3mg in coat)   excipient: acacia butyl hydroxybenzoate calcium phosphate calcium sulfate carnauba wax colophony red lake blend no. 9539 opalux no. as1606 red (solids) gelatin neutral white soap, ts type lactose monohydrate magnesium stearate maize starch oleic acid purified talc starch sucrose white beeswax zein active: dexchlorpheniramine maleate 6mg (3mg in core and 3mg in coat) excipient: acacia butyl hydroxybenzoate calcium phosphate calcium sulfate carnauba wax colophony red lake blend no. 9539 opalux no. as1606 red (solids) gelatin neutral white soap, ts type lactose monohydrate magnesium stearate oleic acid purified talc starch sucrose white beeswax zein

New Zealand - English - Medsafe (Medicines Safety Authority)

schering-plough a division of schering-plough animal health limited - dexchlorpheniramine maleate 6mg (3mg in core and 3mg in coat);  ; pseudoephedrine sulfate 120mg (60mg in core and 60mg in coat.);   - modified release tablet - active: dexchlorpheniramine maleate 6mg (3mg in core and 3mg in coat)   pseudoephedrine sulfate 120mg (60mg in core and 60mg in coat.)   excipient: acacia calcium phosphate calcium sulfate calcium sulfate dihydrate carnauba wax colophony docusate sodium indigo carmine neutral white soap, ts type lactose monohydrate magnesium stearate maize starch   oleic acid povidone   purified talc sucrose titanium dioxide white beeswax zein

Singapore - English - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - dexchlorpheniramine maleate - tablet, sugar coated - 6 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - dexchlorpheniramine maleate, quantity: 2 mg - tablet, uncoated - excipient ingredients: pregelatinised maize starch; maize starch; lactose monohydrate; magnesium stearate - polaramine is indicated for symptomatic treatment of perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild uncomplicated allergic skin manifestations of urticaria and angioedema. polaramine may relieve itching due to skin conditions such as allergic eczema, pruritus ani, pruritus vulvae, atopic dermatitis, contact dermatitis, insect bites, dermographism and drug reactions, including serum sickness.

United States - English - NLM (National Library of Medicine)

foxland pharmaceuticals, inc. - dexchlorpheniramine maleate (unii: b10yd955qw) (dexchlorpheniramine - unii:3q9q0b929n) - perennial and seasonal allergic rhinitis vasomotor rhinitis allergic conjunctivitis due to inhalant allergens and foods mild, uncomplicated allergic skin manifestations of urticaria and angioedema amelioration of allergic reactions to blood or plasma dermographism as therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled. this drug should not be used in newborn or premature infants. because of the higher risk of antihistamines for infants generally and for newborns and prematures in particular, antihistamine therapy is contraindicated in nursing mothers. antihistamines should not be used to treat lower respiratory tract symptoms including asthma. antihistamines are also contraindicated in the following conditions:

Australia - English - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - dexchlorpheniramine maleate, quantity: 2 mg - tablet, uncoated - excipient ingredients: maize starch; magnesium stearate; pregelatinised maize starch; lactose - allerclear is indicated for symptomatic treatment of perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild uncomplicated allergic skin manifestations of urticaria and,angioedema. allerclear may relieve itching due to skin conditions such as allergic eczema, pruritus ani, pruritus vulvae, atopic dermatitis, contact dermatitis, insect bites, dermographism and medicine reactions, including serum sickness.

Australia - English - Department of Health (Therapeutic Goods Administration)

metina australia pty ltd - dexchlorpheniramine maleate, quantity: 2 mg - tablet, uncoated - excipient ingredients: maize starch; pregelatinised starch; lactose monohydrate; magnesium stearate; purified water - for the symptomatic treatment of perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild uncomplicated allergic skin manifestations of urticaria and angioedema. it may relieve itching due to skin conditions such as allergic eczema, pruritus ani, pruritus vulvae, atopic dermatitis, contact dermatitis, insect bites, dermographism and drug reactions, including serum sickness.

Australia - English - Department of Health (Therapeutic Goods Administration)

bioinnova pty ltd - dexchlorpheniramine maleate, quantity: 2 mg - tablet, uncoated - excipient ingredients: maize starch; lactose monohydrate; pregelatinised starch; magnesium stearate; purified water - for the symptomatic treatment of perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild uncomplicated allergic skin manifestations of urticaria and angioedema. it may relieve itching due to skin conditions such as allergic eczema, pruritus ani, pruritus vulvae, atopic dermatitis, contact dermatitis, insect bites, dermographism and drug reactions, including serum sickness.

Australia - English - Department of Health (Therapeutic Goods Administration)

bioinnova pty ltd - dexchlorpheniramine maleate, quantity: 2 mg - tablet, uncoated - excipient ingredients: purified water; magnesium stearate; lactose monohydrate; maize starch; pregelatinised starch - for the symptomatic treatment of perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild uncomplicated allergic skin manifestations of urticaria and angioedema. it may relieve itching due to skin conditions such as allergic eczema, pruritus ani, pruritus vulvae, atopic dermatitis, contact dermatitis, insect bites, dermographism and drug reactions, including serum sickness.

New Zealand - English - Medsafe (Medicines Safety Authority)

bayer new zealand limited - dexchlorpheniramine maleate 2mg;  ; dexchlorpheniramine maleate 2mg - film coated tablet - 2 mg - active: dexchlorpheniramine maleate 2mg   excipient: lactose monohydrate magnesium stearate maize starch starch active: dexchlorpheniramine maleate 2mg excipient: lactose monohydrate magnesium stearate maize starch starch